IV
Inventiva S.A.
IVA.PA · PAR
2.96 € +3.87% (+0.11 €)
1M -29.63%
Market Cap 674.4M €
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 150.44x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 28.33%
EPS growth N/A
FCF growth N/A
Profitability
14 /100
Weak Gross margin 35.07%
Net margin 7,899.58%
Op. margin 3,040.98%
Quality
0 /100
Poor ROIC 66.26%
ROA 141.93%
Asset turnover 0.02x
Debt
43 /100
Moderate Current ratio 3.16x
Int. coverage -4.06x
Debt/Equity N/A
Stability
32 /100
Unstable Beta 0.92x
Rev. volatility 56.55%
EPS volatility 61.93%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IVA.PA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew Obenshain
Employees
73
Headquarters
Daix